Ruckenstein Michael J, Shepard Neil T
Department of Otorhinolaryngology, Head and Neck Surgery and Balance Center, The University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA.
ORL J Otorhinolaryngol Relat Spec. 2007;69(5):295-8. doi: 10.1159/000105265. Epub 2007 Jul 6.
To evaluate the efficacy of mastoid oscillation performed with a canalith repositioning procedure (CRP) for the treatment of benign paroxysmal positional vertigo (BPPV).
A total of 137 patients with posterior canal BPPV were treated with an Epley CRP with or without mastoid oscillation at a tertiary care, university-based balance center. Data were collected prospectively from all patients via a preprinted diary which they maintained for 14 days after the maneuver. Patients underwent office evaluation at 2 weeks after the maneuver.
A total of 137 patients were divided equally between the treatment groups. At 48 h post-treatment, 61% (with vibration) and 64% (without vibration) of patients were free of vertigo. At 2 weeks' post-treatment, 74% (with vibration) and 85% (without vibration) were vertigo-free. Residual symptoms of lightheadedness/imbalance were experienced by 32% of patients with vibration and 40% of patients without vibration. None of these differences between groups were statistically significant.
The addition of mastoid oscillation to the positioning maneuver does not add any therapeutic benefit.
评估采用半规管结石复位法(CRP)进行乳突振动治疗良性阵发性位置性眩晕(BPPV)的疗效。
在一家大学附属三级医疗平衡中心,对137例后半规管BPPV患者采用Epley CRP进行治疗,部分患者同时进行乳突振动。通过预印的日记前瞻性收集所有患者的数据,患者在手法治疗后需记录14天。手法治疗2周后对患者进行门诊评估。
治疗组患者平均分为两组。治疗后48小时,61%(有振动)和64%(无振动)的患者眩晕症状消失。治疗后2周,74%(有振动)和85%(无振动)的患者眩晕症状消失。有振动组32%的患者和无振动组40%的患者仍有残留的头晕/失衡症状。两组之间的这些差异均无统计学意义。
在定位手法中增加乳突振动并无任何治疗益处。